Use of Nonselective β-Blockers in Patients With End-Stage Liver Disease and Select Complications

Amanda C. Bultas, Besu Teshome, Sara K. Richter, Stephen Schafers, Emily Cooke, William B. Call

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)583-593
Number of pages11
JournalAnnals of Pharmacotherapy
Volume54
Issue number6
DOIs
StatePublished - Jun 1 2020

ASJC Scopus Subject Areas

  • Pharmacology (medical)

Keywords

  • carvedilol
  • cirrhosis
  • end-stage liver disease
  • nadolol
  • nonselective β-blocker
  • propranolol

Cite this